U.S. government awards $45 million for long COVID clinics
Send a link to a friend
[September 21, 2023]
By Ahmed Aboulenein
WASHINGTON (Reuters) - The U.S. government is awarding $45 million in
grants to help clinics treating long COVID develop new models of care
and expand access, the Department of Health and Human Services (HHS)
said on Wednesday.
Nine clinics will receive $1 million grants annually over the next five
years through the Agency for Healthcare Research and Quality (AHRQ)
within HHS, the department said.
President Joe Biden had tasked HHS last year with developing a national
action plan to tackle long COVID, a complex, multi-symptom condition
that arises months after a COVID-19 infection and leaves many of its
sufferers unable to work.
"The Biden-Harris Administration is supporting patients, doctors and
caregivers by providing science-based best practices for treating long
COVID, maintaining access to insurance coverage, and protecting the
rights of workers as they return to jobs while coping with the
uncertainties of their illness," said HHS Secretary Xavier Becerra.
The funding will be used for increasing in-person and virtual visits,
establishing new satellite clinics, and an education initiative aimed at
growing referrals. Limited knowledge and acceptance among clinicians has
contributed to delays in diagnoses and referrals.
It will also go towards social services, hiring interpreters, group
patient programs, and behavioral health support. The grants prioritize
access for underserved, rural, vulnerable, and minority populations that
are disproportionately impacted by long COVID.
[to top of second column]
|
U.S. President Joe Biden poses for a selfie with a family during a
visit to a coronavirus disease (COVID-19) vaccination clinic hosted
by the District of Columbia's Department of Health (DC Health) and
offering vaccinations to children under age five, at the Church of
the Holy Communion in Washington, U.S., June 21, 2022. REUTERS/Kevin
Lamarque
The condition affects nearly 7% of
all U.S. adults and 2.3% of the overall population and has cost an
estimated $386 billion in lost wages, savings and medical bills,
according to an analysis in April by the Solve Long Covid
Initiative, a non-profit research and advocacy group.
More than 200 symptoms have been linked to the syndrome - including
extreme fatigue, difficulty thinking, headaches, dizziness when
standing, sleep problems, chest pain, blood clots, immune
dysregulation, and even diabetes.
No proven treatments are available but research is underway. The
National Institute of Health (NIH) is conducting a $1.15 billion
effort, the RECOVER program, which launched two clinical trials in
July that will evaluate at least four potential treatments.
(Reporting by Ahmed Aboulenein; Editing by Richard Chang)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|